Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. Amid Successful ZUNVEYL® Commercialization

Reuters
08/16
Stonegate Capital Partners Updates Coverage on <a href="https://laohu8.com/S/ACOGD">Alpha Cognition Inc.</a> Amid Successful ZUNVEYL® Commercialization

Stonegate Capital Partners has updated its coverage on Alpha Cognition Inc. (NASDAQ: ACOG) following the company's first full quarter of ZUNVEYL® commercialization. This period saw significant early adoption in the U.S. long-term care market and a key regulatory milestone in China. ZUNVEYL has been ordered in over 300 long-term care facilities with 65% placing repeat orders. Additionally, Alpha Cognition secured its first national Medicare Part D contract, enhancing patient access. For more details, visit newsfilecorp.com/release/177020.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 262742) on August 15, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10